Polycystic Ovary Syndrome

PCOS affects roughly one in ten women of reproductive age and remains one of the most under-treated endocrine conditions in primary care. The diagnosis itself is heterogeneous: some women present with androgen excess and acne, others with insulin resistance and weight gain, and many with overlapping features that resist a single intervention. The standard approach of oral contraceptives and metformin addresses symptoms without examining the underlying metabolic and hormonal architecture.

At Manus Solis, we treat PCOS as the metabolic-endocrine condition it is. We map the full hormonal landscape through comprehensive bloodwork, assess insulin dynamics with fasting insulin and HOMA-IR, and track your progress across all three Vis Viva Score domains. Treatment is individually compounded and titrated to response: how you feel, what your labs show, and what your body can do.

We address each phenotype individually. Insulin-resistant presentations receive targeted metabolic support, including pharmaceutical-grade nutraceuticals, and when indicated, insulin-sensitizing agents. Androgen excess is managed through hormonal optimization rather than suppression alone. Bioidentical progesterone may be prescribed where luteal insufficiency is present. Every protocol is compounded by our Ontario pharmacy partner and adjusted based on serial bloodwork, symptom tracking, and functional metrics.

Women with a confirmed or suspected PCOS diagnosis who want a thorough hormonal and metabolic evaluation beyond oral contraceptives. Patients who have been told to 'just lose weight' and want a physician who will investigate the reasons weight loss is difficult in the first place.